Powder: -20°C for 3 years | In solvent: -80°C for 1 year
ML351 is a potent and selective inhibitor of human 15-lipoxygenase-1 (15 LOX)(IC50: 200 nM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 55.00 | |
2 mg | In stock | $ 81.00 | |
5 mg | In stock | $ 126.00 | |
10 mg | In stock | $ 207.00 | |
25 mg | In stock | $ 448.00 | |
50 mg | In stock | $ 658.00 | |
100 mg | In stock | $ 938.00 | |
500 mg | In stock | $ 1,890.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 148.00 |
Description | ML351 is a potent and selective inhibitor of human 15-lipoxygenase-1 (15 LOX)(IC50: 200 nM). |
Targets&IC50 | 15-LOX:200 nM |
In vitro | ML351 exhibited nanomolar potency and excellent selectivity (>250-fold) versus 5-LOX, platelet 12-LOX, 15-LOX-2, ovine COX-1, and human COX-2. In mouse neuronal HT22 cells, ML351 dose-dependently protected against oxidative glutamate toxicity and completely reversed the increase in 12-HETE following glutamate treatment [2][3] |
Molecular Weight | 249.27 |
Formula | C15H11N3O |
CAS No. | 847163-28-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 22.5 mg/mL (90.26 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
ML351 847163-28-4 Metabolism Lipoxygenase Subarachnoid hemorrhage ML-351 inhibit oxidative stress SAH neuronal ML 351 LOX T1D β-cell Inhibitor non-obese diabetic inhibitor